pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
IL-23 · news · pharmadog
← back to IL-23
News · IL-23
10
stories
Aug 5, 26
Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO
fiercebiotech
Aug 4, 26
Merck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trials
fiercebiotech
Jul 27, 26
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
fiercebiotech
Jul 16, 26
Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 update
fiercebiotech
Jul 15, 26
Braveheart, Attovia join next wave of biotech IPOs
biopharma dive
Jul 14, 26
Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill
biopharma dive
Jul 14, 26
STAT+: Akero team, backed by Fairmount, launches new immunology company
stat
May 6, 26
Avalo shares spike on skin drug data; BioNTech to cut staff
biopharma dive
Apr 28, 26
Coultreon banks $125M to support testing of former Galapagos immune drug
biopharma dive
Apr 27, 26
Oruka surges as long-acting psoriasis drug shows early promise
biopharma dive
